Lonza | LONN - Loan Capital


Lonza reported CHF3.88B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Akzo Nobel EUR 4.76B 1.09B Mar/2026
Alcon AG USD 4.16B 434M Mar/2026
Almirall EUR 324.81M 61.32M Dec/2025
AstraZeneca USD 25.96B 177M Mar/2026
BASF EUR 18.48B 447M Dec/2025
Bayer EUR 30.68B 1.15B Mar/2026
Beiersdorf EUR 117M 15M Dec/2025
Covestro EUR 1.67B 408M Dec/2025
Demant DKK 18.98B 3.71B Dec/2025
Fresenius EUR 9.22B 1.58B Dec/2025
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Geberit CHF 1.35B 25.4M Sep/2025
Genmab DKK 5.14B 5.01B Dec/2025
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GN Store Nord DKK 8.1B 790M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Johnson Matthey GBP 1.35B 2M Jun/2026
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Philips EUR 6.89B 43M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Sika AG CHF 4.13B 1.4B Dec/2025
Smith & Nephew USD 3.3B 22M Dec/2025
Solvay EUR 1.83B 8M Mar/2026
UCB EUR 2.18B 634M Dec/2025